Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.705
+0.105 (4.04%)
At close: Feb 13, 2026, 4:00 PM EST
2.650
-0.055 (-2.03%)
After-hours: Feb 13, 2026, 4:10 PM EST
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $102.28 million as of February 13, 2026. Its market cap has decreased by -54.46% in one year.
Market Cap
102.28M
Enterprise Value
2.34M
1-Year Change
-54.46%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $102.28M, a decrease of -79.05%. That is a compound annual growth rate of -28.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 102.28M | -10.17% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apyx Medical | 152.63M |
| LENSAR | 146.08M |
| CVRx, Inc. | 130.24M |
| AVITA Medical | 127.43M |
| Treace Medical Concepts | 118.52M |
| Picard Medical | 114.97M |
| Hyperfine | 107.86M |
| Neuronetics | 97.25M |